Methylene blue was developed in the 1800s as a cobalt blue synthetic dye for textiles, but it also has some medicinal uses. It's approved to treat a rare blood disorder called methemoglobinemia.

An infant botulism outbreak has sickened at least 39 babies across the U.S., underscoring the crucial role of a medication that treats the rare disease.